Table 2.
Polypill arm, n=812, 19.2% | Minimal care arm, n=760, 18.2% | |
---|---|---|
Hypersensitivity to one of components of polypill | 12(0.28) | 7(0.17) |
History of angioedema | 1(0.02) | 1(0.02) |
History of gastrointestinal bleeding or peptic ulcer disease in last 3 months | 13(0.31) | 12(0.29) |
History of stroke | 37(0.87) | 58(1.39) |
Pregnancy or lactation | - | - |
Bleeding disorders such as hemophilia | 1(0.02) | 1(0.02) |
Regular anticoagulant use | 25(0.59) | 16(0.38) |
Alcohol consumption | 2(0.05) | 1(0.02) |
Advanced liver disease | 25(0.59) | 18(0.43) |
Uncontrolled seizures | 10(0.24) | 14(0.34) |
Severe asthma | 108(2.55) | 143(3.42) |
History of gout | 2(0.05) | 1(0.02) |
Serum creatinine > 2 mg/dL | 27(0.64) | 31(0.74) |
Glomerular filtration rate < 30 ml/min | 52(1.23) | 64(1.53) |
Hemoglobin<10 mg/dL in females and <11 mg/dL in males | 210(4.96) | 191(4.57) |
Systolic blood pressure <90 mmHg and diastolic blood pressure < 60 mmHg | 91(2.15) | 37(0.89) |
Medical/psychiatric comorbidities | 305(7.21) | 309(7.4) |
Unavailability of the subjects | 28(0.66) | 2(0.05) |
Note: Each subject may meet more than one exclusion criterion